100 related articles for article (PubMed ID: 16537563)
1. Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study.
Huirne JA; Hugues JN; Pirard C; Fischl F; Sage JC; Pouly JL; Obruca A; Braat DM; van Loenen AC; Lambalk CB
Hum Reprod; 2006 Jun; 21(6):1408-15. PubMed ID: 16537563
[TBL] [Abstract][Full Text] [Related]
2. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.
Andersen AN; Witjes H; Gordon K; Mannaerts B;
Hum Reprod; 2011 Dec; 26(12):3413-23. PubMed ID: 21954280
[TBL] [Abstract][Full Text] [Related]
4. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.
Albano C; Felberbaum RE; Smitz J; Riethmüller-Winzen H; Engel J; Diedrich K; Devroey P
Hum Reprod; 2000 Mar; 15(3):526-31. PubMed ID: 10686191
[TBL] [Abstract][Full Text] [Related]
5. Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH.
Levi-Setti PE; Cavagna M; Bulletti C
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):212-6. PubMed ID: 16377062
[TBL] [Abstract][Full Text] [Related]
6. A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy.
Xavier P; Gamboa C; Calejo L; Silva J; Stevenson D; Nunes A; Martinez-de-Oliveira J
Eur J Obstet Gynecol Reprod Biol; 2005 Jun; 120(2):185-9. PubMed ID: 15925049
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized trial.
Cédrin-Durnerin I; Guivarc'h-Levêque A; Hugues JN;
Fertil Steril; 2012 Jun; 97(6):1359-64.e1. PubMed ID: 22464760
[TBL] [Abstract][Full Text] [Related]
8. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.
Borm G; Mannaerts B
Hum Reprod; 2000 Jul; 15(7):1490-8. PubMed ID: 10875855
[TBL] [Abstract][Full Text] [Related]
9. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
10. Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients.
Moraloglu O; Kilic S; Karayalçin R; Yuksel B; Tasdemir N; Işik A; Ugur M
Adv Ther; 2008 Mar; 25(3):266-73. PubMed ID: 18345521
[TBL] [Abstract][Full Text] [Related]
11. Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration.
Lee TH; Wu MY; Chen HF; Chen MJ; Ho HN; Yang YS
Fertil Steril; 2005 Jun; 83(6):1700-7. PubMed ID: 15950639
[TBL] [Abstract][Full Text] [Related]
12. Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients.
Hosseini MA; Aleyasin A; Saeedi H; Mahdavi A
J Obstet Gynaecol Res; 2010 Jun; 36(3):605-10. PubMed ID: 20598044
[TBL] [Abstract][Full Text] [Related]
13. Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.
Nyachieo A; Spiessens C; Chai DC; Mwenda JM; D'Hooghe TM
Fertil Steril; 2009 Feb; 91(2):602-10. PubMed ID: 18328482
[TBL] [Abstract][Full Text] [Related]
14. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome.
Ragni G; Vegetti W; Riccaboni A; Engl B; Brigante C; Crosignani PG
Hum Reprod; 2005 Sep; 20(9):2421-5. PubMed ID: 15890731
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
16. Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study.
Lin YH; Hwang JL; Seow KM; Huang LW; Hsieh BC; Tzeng CR
Gynecol Endocrinol; 2006 Jun; 22(6):297-302. PubMed ID: 16785154
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study.
Cédrin-Durnerin I; Grange-Dujardin D; Laffy A; Parneix I; Massin N; Galey J; Théron L; Wolf JP; Conord C; Clément P; Jayot S; Hugues JN
Hum Reprod; 2004 Sep; 19(9):1979-84. PubMed ID: 15192072
[TBL] [Abstract][Full Text] [Related]
18. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
19. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial.
Cheung LP; Lam PM; Lok IH; Chiu TT; Yeung SY; Tjer CC; Haines CJ
Hum Reprod; 2005 Mar; 20(3):616-21. PubMed ID: 15608037
[TBL] [Abstract][Full Text] [Related]
20. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
